Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Hamit B"'
Autor:
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Ozkan Alan, Sermin Coban Kokten, Deniz Isik, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabas, Mahmut Emre Yildirim, Nedim Turan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Neoadjuvant chemotherapy (NACT) is the standard treatment for locally advanced, high-risk breast cancer. Pathological complete response (pCR) improves survival. Peripheral blood-derived indices reflecting systemic inflammation and nutritiona
Externí odkaz:
https://doaj.org/article/1a1cba80adca4b45bbb0a31a1f079759
Publikováno v:
Genel Tıp Dergisi, Vol 34, Iss 1, Pp 109-113 (2024)
Background/Aims: Different optimization methods in brachytherapy treatment planning is used. The aim of this study is to evaluate dosimetric differences between manual optimization (MO) and inverse planning simulated annealing (IPSA) planning techniq
Externí odkaz:
https://doaj.org/article/35c3255da170408ca3b8213ee10ec095
Publikováno v:
In International Journal of Oral & Maxillofacial Surgery September 2017 46(9):1118-1120
Autor:
Oğuzcan Kınıkoğlu, Hatice Odabas, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yıldırım, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yıldırım, Nedim Turan
Publikováno v:
Medicina, Vol 60, Iss 6, p 951 (2024)
Background and Objectives: Patients with human epidermal growth factor receptor 2 (HER2) -positive, hormone receptor-positive (HR-positive) metastatic breast cancer (MBC) usually undergo trastuzumab emtansine (T-DM1) therapy in subsequent lines. Comb
Externí odkaz:
https://doaj.org/article/6ffb7c6ff0a64dc68ddaa9958c580ba2
Publikováno v:
Journal of Contemporary Medicine, Vol 13, Iss 2, Pp 204-208 (2023)
Abstract Objective: The aim of this study is to report the survival and treatment results of patients with cervical esophageal cancer treated with definitive chemoradiotherapy, whose incidence is very low in the population and there is not enough inf
Externí odkaz:
https://doaj.org/article/affc573caa6a4cbdb2e95cd6b51b4f99
Publikováno v:
Middle East Journal of Cancer, Vol 13, Iss 3, Pp 523-530 (2022)
Background: The present dosimetric study aimed to evaluate the dosimetric benefits of using three-dimensional conformal radiotherapy (3D-CRT), dynamic intensity-modulated radiation therapy (D-IMRT), and Hybrid CRT/IMRT plans. Method: In this dosimetr
Externí odkaz:
https://doaj.org/article/fe54c57d311a48168d0c5ef8181b11dd
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 1-7 (2022)
Aim:The aim of this study was to compare dosimetric advantages of using intensity-modulated radiation therapy (IMRT) and simultaneous-boost (SIB-IMRT) techniques for glioblastoma multiform (GBM).Materials and Methods:Ten patients with GBM were retros
Externí odkaz:
https://doaj.org/article/daf37d3c9e88485db6767e1696052a47
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 33, Iss 1, Pp 1-8 (2021)
Abstract Background Cancer is one of the leading causes of death worldwide. According to GLOBOCAN estimates, there were 341,831 deaths from cervical cancer in 185 countries in 2020. The aim of this study was to compare equieffective dose (EQD2) at 2
Externí odkaz:
https://doaj.org/article/34a515522a574839b06ff3e41b0a46c2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.